Clinical Trials in Seattle

Showing 4081-4100 of 9,312 trials

AIMS Medical Outcomes Study

NCT04512755

This epidemiologic research is being conducted as an observational prospective case series outcomes study of the use of advanced integrative specialty medical care and its effect on adult and pediatric patients with chronic or serious illnesses or mental health disorders.

Mental Health IssuePTSDPain+2 more

Advanced Integrative Medical Science Institute500 participantsStarted Jul 2020

Seattle, Washington, United States

RECRUITING< 1 mile

AIMS Cancer Outcomes Study

NCT04495790

The overall aim is to describe disease-free survival (DFS) in early stage cancer patients and three-year overall survival (OS) outcomes in advanced stage cancer patients receiving Advanced Integrative Oncology (AIO) treatment in a prospective consecutive case series outcomes study. We will collect data and study outcomes for patients with cancer who receive care at AIMS Institute.

NeoplasmsNeoplasm MalignantAdvanced Cancer+2 more

Advanced Integrative Medical Science Institute500 participantsStarted May 2020

Seattle, Washington, United States

COMPLETEDPhase 3< 1 mile

Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis

NCT03624127

The purpose of this study is to investigate the experimental medication BMS-986165 compared to placebo and a currently available treatment in participants with moderate to severe plaque psoriasis.

Psoriasis

Bristol-Myers Squibb666 participantsStarted Aug 2018

Birmingham, Alabama, United States • Mobile, Alabama, United States • Phoenix, Arizona, United States +162 more locations

AIMS Medical Outcomes Study

AIMS Cancer Outcomes Study

Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis

Find Trials by Condition in Seattle

A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC)

A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19

Outcome pRognostication of Acute Brain Injury With the NeuroloGical Pupil indEx

Gamma Knife Radiosurgery for Treatment of Essential Tremor

Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host Disease

Radiation Therapy in Treating Patients With Stage II Prostate Cancer

Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity

Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection

NDT Effectiveness Study

Neuro RX Gamma - Pivotal Phase

Thoracolumbar Burst Fractures Study Comparing Surgical Versus Non-surgical Treatment

Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC

Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder

Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion

Cholangioscopy in Primary Sclerosing Cholangitis (PSC)